Jiani Wu

1838 North Guangzhou Avenue
Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Corrigendum to Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer [iScience Volume 29, Issue 3, March 2026, Article e114872].

Corrigendum to Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer [iScience Volume 29, Issue 3, March 2026, Article e114872].

Journal: iScience
Published: July 02, 2026

Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer.

Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer.

Journal: iScience
Published: February 20, 2026

PFKFB3 confers cisplatin resistance in gastric cancer by inhibiting ferroptosis through SLC7A11/xCT dephosphorylation.

PFKFB3 confers cisplatin resistance in gastric cancer by inhibiting ferroptosis through SLC7A11/xCT dephosphorylation.

Journal: International immunopharmacology
Published: March 05, 2025

Post-marketing safety surveillance of Amivantamab: a real world study based on the FDA adverse event reporting system.

Post-marketing safety surveillance of Amivantamab: a real world study based on the FDA adverse event reporting system.

Journal: Expert opinion on drug safety
Published: February 26, 2025

Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials.

Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 02, 2025

Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in Cancer.

Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 26, 2024

Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy.

Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy.

Journal: BMC cancer
Published: October 21, 2024

Dynamic single-cell sequencing unveils the tumor microenvironment evolution of gastric cancer abdominal wall metastases during radiotherapy.

Dynamic single-cell sequencing unveils the tumor microenvironment evolution of gastric cancer abdominal wall metastases during radiotherapy.

Journal: Cancer science
Published: March 29, 2024

Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trial.

Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trial.

Journal: Med (New York, N.Y.)
Published: February 06, 2024

Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer.

Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer.

Journal: iScience
Published: October 19, 2023

Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.

Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.

Journal: Journal for immunotherapy of cancer
Published: July 08, 2021

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.

Journal: Frontiers in immunology
Published: March 30, 2021
Showing 1-12 of 17

Last Updated: 09/26/2026